iHuman Inc. IH
1.07 USD +0.05 (+4.90%)
At closeNov 11, 2026, 4:00 PM EST
1.07 0.00 +0.02%
After hours · Nov 11, 4:00 PM ET
1.00 Day range 1.07
1.00 52-week range 2.99
- YTD
- -49.05%
- 1 year
- -60.52%
News
gurufocus.com Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1 Takeda ([url="]TSE:4502/NYSE: TAK[/url])announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (N
gurufocus.com Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference [url="]Vertex Pharmaceuticals Incorporated[/url] (Nasdaq: VRTX) today announced new interim data from the ALYFTREKÂ (vanzacaftor/tezacaftor/deutivacaftor) 2 to
defenseworld.net Head-To-Head Contrast: IMAX (NYSE:IMAX) versus iHuman (NYSE:IH) iHuman (NYSE: IH - Get Free Report) and IMAX (NYSE: IMAX - Get Free Report) are both communication services companies, but which is the superior stock? We will contrast the two businesses based on…
benzinga.com iHuman Q2 Adj. EPS $(0.05) Down From $0.08 YoY, Sales $25.553M Down From $27.942M YoY iHuman (NYSE:IH) reported quarterly losses of $(0.05) per share. This is a 162.5 percent decrease over earnings of $0.08 per share from the same period last year. The company reported $25.553 million…
prnewswire.com iHuman Inc. Announces Second Quarter 2026 Unaudited Financial Results BEIJING, Sept. 29, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered knowledge and personal growth products, today announced its unaudited…
gurufocus.com New England Journal of Medicine Publishes Data from Phase 3 Studies Demonstrating Oveporexton (ORZEYFUL) Improved the Full Range of Narcolepsy Type 1 Symptoms and Quality of Life Takeda (TSE:4502/NYSE: TAK) announced that the [url="]New England Journal of Medicine[/url] published results from two Phase 3 studies evaluating oveporexton (OR
gurufocus.com ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 Takeda ([url="]TOKYO:4502/NYSE: TAK[/url]) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) f
benzinga.com iHuman Q1 Adj. EPS $0.01 Down From $0.07 YoY, Sales $26.456M Down From $28.999M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.01 per share. This is a 85.71 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $26.456 million…
prnewswire.com iHuman Inc. Announces First Quarter 2026 Unaudited Financial Results BEIJING, June 29, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered knowledge and personal growth products, today announced its unaudited…
prnewswire.com Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia New late-breaking data presentations underscore Jazz's significant progress in advancing holistic understanding of narcolepsy and idiopathic hypersomnia, including novel real-world evidence of…
gurufocus.com iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo PR Newswire
prnewswire.com iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo BEIJING, May 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it has…
prnewswire.com iHuman Inc. Files 2025 Annual Report on Form 20-F BEIJING, April 24, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it…
benzinga.com Earnings Scheduled For March 31, 2026 
benzinga.com iHuman Q4 Adj. EPS $0.04 Down From $0.07 YoY, Sales $27.300M Down From $31.878M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.04 per share. This is a 42.86 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $27.300 million…
prnewswire.com iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results BEIJING, March 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its…
benzinga.com 12 Communication Services Stocks Moving In Tuesday's Pre-Market Session 
defenseworld.net iHuman Inc. Sponsored ADR (NYSE:IH) Sees Large Increase in Short Interest iHuman Inc. Sponsored ADR (NYSE: IH - Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 3,198…- benzinga.com Earnings Scheduled For December 29, 2025
benzinga.com iHuman Q3 Adj. EPS $0.06 Down From $0.07 YoY, Sales $28.900M Down From $34.115M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.06 per share. This is a 14.29 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $28.900 million…
prnewswire.com iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results BEIJING , Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its…
seekingalpha.com iHuman: Undervalued With Geographical Expansion Upside iHuman (IH) offers educational apps and devices, trading at a deep discount to global peers and below its cash value, signaling undervaluation. IH is expanding internationally, notably in the US…
newsfilecorp.com iHuman to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference Beijing, China--(Newsfile Corp. - November 24, 2025) - iHuman Inc. (NYSE: IH), a leading provider of tech-powered, intellectual development products in China, today announced that its Investor…- benzinga.com 12 Communication Services Stocks Moving In Wednesday's After-Market Session
benzinga.com iHuman's International Push Boosted By Cricket Media Tie-up 
benzinga.com iHuman Q2 Adj. EPS $0.08 Up From $0.06 YoY, Sales $27.942M Down From $29.600M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.08 per share. This is a 33.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $27.942 million…
prnewswire.com iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results BEIJING , Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its…
prnewswire.com iHuman and Cricket Media Team Up to Launch Reading Stars Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va.- benzinga.com 12 Communication Services Stocks Moving In Thursday's Pre-Market Session
benzinga.com iHuman Reported Q1 2025 MAUs Of 26.5M Vs 26.4M YoY iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first…
prnewswire.com iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results BEIJING , June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its…
prnewswire.com iHuman Inc. Files 2024 Annual Report on Form 20-F BEIJING , April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it…- benzinga.com iHuman Q4 Adj $0.07 Down From $0.09 YoY, Sales $31.88M Beat $30.74M Estimate iHuman (NYSE:IH) reported quarterly earnings of $0.07 per share. This is a 22.22 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales…
benzinga.com 12 Communication Services Stocks Moving In Wednesday's Intraday Session - benzinga.com 12 Communication Services Stocks Moving In Thursday's Pre-Market Session
- benzinga.com Tesla, Toyota And 3 Stocks To Watch Heading Into Thursday
benzinga.com iHuman's Q3 MAUs Rose 14.8% YoY To 29.12M Average total MAUs for the quarter were 29.12 million, an increase of 14.8% year-over-year from 25.36 million in the same period last year, primarily due to the effective execution of our user…- benzinga.com iHuman Extends Share Buyback Program By Another 12 Months Through End of 2025 Given its confidence in the Company's business prospects, the board of directors (the "Board") has authorized an extension of the Company's existing share repurchase program, as authorized in…
- benzinga.com 12 Communication Services Stocks Moving In Monday's Intraday Session
benzinga.com iHuman Misses China Stock Rally As Investors Fret Over Stumbling Growth Key Takeaways: iHuman’s revenue and profit both declined in the first quarter as it accelerated a global expansion plan to diversify beyond its softening home market in China The company’s gross…- benzinga.com 12 Communication Services Stocks Moving In Monday's Pre-Market Session
- benzinga.com Earnings Scheduled For February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
- benzinga.com iHuman Q4 Adj. EPADS $0.09 Down From $0.11 YoY, Sales $35.27M Down From $37.80M YoY iHuman (NYSE:IH) reported quarterly adjsuted earnings of $0.09 per share. This is a 18.18 percent decrease over earnings of $0.11 per share from the same period last year. The company reported $35.27…
- benzinga.com Overview Of Value Stocks In The Consumer Defensive Sector
- benzinga.com 5 Value Stocks To Watch In The Consumer Defensive Sector
benzinga.com 5 Value Stocks In The Consumer Defensive Sector - benzinga.com iHuman Average Total MAUs Q3 Were 25.36M, Up By 22.9% YoY Average total MAUs for the quarter were 25.36 million, an increase of 22.9% year-over-year from 20.63 million in the same period last year. The number of paying users was 1.54 million.
- benzinga.com iHuman Q3 EPS $0.14 Up From $0.11 YoY, Sales $35.80M Up From $35.36M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.14 per share. This is a 27.27 percent increase over earnings of $0.11 per share from the same period last year. The company reported $35.80 million…
- benzinga.com Overview Of Value Stocks In The Consumer Defensive Sector
- benzinga.com 5 Value Stocks To Watch In The Consumer Defensive Sector